| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Chemistry [A. R. M.], The University of Toledo; Surgery/Urology [S. H. S., K. C., R. W. K., G. M. G.] and Biochemistry [M. K. B.], Medical College of Ohio; and Research Department and Porphyrin Laboratory [M. K. B., G. M. G.], St. Vincent Medical Center; Toledo, Ohio 43608
Purpurin derivatives, a group of synthetic photosensitizers, were tested for their photodynamic activity against transplantable N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced urothelial tumors growing in male Fischer 344 rats. Histological examination of tumors in animals treated with the purpurin derivatives and red light (>590 nm, 360 joules/cm2) revealed tumor cell necrosis 24 h after completion of therapy. Control tumors showed no histological change.
Purpurins have a major absorption peak in the red region (>650 nm) of the visible spectrum, a region with good tissue penetration, and purpurins can be synthesized with a high degree of purity. This study demonstrates the potential of purpurin derivatives as photosensitizers for photodynamic cancer therapy.
1 This work was supported in part by grants from the Geiger Foundation for Cancer Research and the F.M. Douglass Foundation and by the New Investigator Award (NIH R23-CA38754-01).
2 To whom requests for reprints should be addressed, at Department of Chemistry, University of Toledo, Toledo, OH 43606.
Received 8/ 6/86. Accepted 10/ 9/86.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |